首页> 外国专利> Classification of lung carcinomas using gene expression analysis

Classification of lung carcinomas using gene expression analysis

机译:基于基因表达分析的肺癌分类

摘要

The invention provides a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Oligonucleotide microarrays were used to analyze mRNA expression levels corresponding to 12,600 transcript sequences in 186 lung tumor samples, including 139 adenocarcinomas resected from the lung. Hierarchical and probabilistic clustering of expression data defined distinct subclasses of lung adenocarcinoma. Among these were tumors with high relative expression of neuroendocrine genes and of type II pneumocyte genes, respectively. Retrospective analysis revealed a less favorable outcome for the adenocarcinomas with neuroendocrine gene expression. The diagnostic potential of expression profiling is emphasized by its ability to discriminate primary lung adenocarcinomas from metastases of extrapulmonary origin. These results suggest that integration of expression profile data with clinical parameters could aid in diagnosis of lung cancer patients.
机译:本发明提供了肺癌的分子分类学,肺癌是美国和世界范围内癌症死亡的主要原因。寡核苷酸微阵列用于分析186个肺肿瘤样品(包括从肺切除的139个腺癌)中对应于12,600个转录物序列的mRNA表达水平。表达数据的分层和概率聚类定义了肺腺癌的不同亚类。其中分别是神经内分泌基因和II型肺细胞基因相对表达高的肿瘤。回顾性分析显示具有神经内分泌基因表达的腺癌的预后较差。表达谱的诊断潜力被其区分原发性肺腺癌和肺外起源转移的能力所强调。这些结果表明表达谱数据与临床参数的整合可以帮助诊断肺癌患者。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号